Table: begin end state 1 11 non-cytoplasmic 12 31 transmembrane 32 41 cytoplasmic 42 59 transmembrane 60 64 non-cytoplasmic 65 88 transmembrane 89 97 cytoplasmic 98 118 transmembrane 119 144 non-cytoplasmic 145 164 transmembrane 165 185 cytoplasmic 186 210 transmembrane 211 228 non-cytoplasmic 229 251 transmembrane 252 256 cytoplasmic 257 277 transmembrane 278 282 non-cytoplasmic 283 301 transmembrane 302 321 cytoplasmic 322 340 transmembrane 341 345 non-cytoplasmic 346 366 transmembrane 367 377 cytoplasmic 378 395 transmembrane 396 400 non-cytoplasmic 401 421 transmembrane 422 426 cytoplasmic 427 446 transmembrane 447 469 non-cytoplasmic 470 487 transmembrane 488 520 cytoplasmic 521 540 transmembrane 541 559 non-cytoplasmic 560 583 transmembrane 584 594 cytoplasmic 595 617 transmembrane 618 646 non-cytoplasmic
Input: >BPHYT_RS21490 FitnessBrowser__BFirm:BPHYT_RS21490 MLSNLLVQLVNGLADASTLFLVAAGLSLIFGVTRIVNFAHGSFYMFGIYVAYSIASRFGH TTGGFWLSVLAAALVVAVLGALVEMVVLRRIYQAPELFHLLATFALVLIFRDAALWLWGP EDLFGPRAPHLAGAVDFLGHPLPTYDIALIVIGPVVLLLLWYALTRTRWGTLVRAATQDR EMLGALGINQAWLFTGVFFVGAFLAGLGGALQGPRMSANLSLDLETIGNAFVVVVVGGMG SIPGAFIAALIIAEIKALCIGIGHVTIFGVGLSLSRFTLVAEFVVMAVVLVVRPWGLLGR ASAAVRGMAAPETPLRPAGKRLKWLAAIALLVLVLAPLAANAFPYMPVLLVEILIAVLFA TSLHFIMGPGGMHSFGHAAYFGLGAYGAALFLKVLNLPMEAALLLGPLLAVAGALVFGWF CVRLSGVYLAMLTLAFAQIVWSVVFQWDDVTGGSNGILGLWPSNWLSSPVAFYYVTLVCA VIGVWLLRKMLFSPLGYAMRASRDSVLRAEAIGIDVKRVQWAAFVIASLFCGLAGSLYAF SKGTISPEVISVSRSVDGLVMVLLGGLQTLTGPIVGAAVFTWLQDTVARQTDYWQALLGF AILLLVIAFPQGIVGFIRERFGDDSADSADKSAVSPSRRAAIKEGL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server